Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gadobutrol-enhanced MRA in Renal Artery Disease
NCT01344460Phase 3Completed
- Sponsor
- Bayer
- Start
- May 2011
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 3 trial of gadobutrol in renal artery stenosis (RAS), sponsored by Bayer. Started May 2011; status: completed.
02
Drugs
gadobutrol
03
Conditions
renal artery stenosis (RAS)
Beyond the preview
Go deeper on NCT01344460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01344460.